Dexcom, Inc. · NASDAQ:DXCM
Dexcom — Q4 2022 Earnings Presentation
12 slides from Dexcom's earnings presentation, Feb 9, 2023
Slide 1: Dexcom earnings Q4 2022
bpexcom Dexcom earnings Q4 2022
Slide 2: Safe Harbor Statement
Safe Harbor Statement pexcom This presentation contains "forward" looking statements that are based on our management's beliefs and assumptions and on information currently available to management. We intend for such forward-looking statements to be covered by the safe harbor provisions for forward-
Slide 3: Fourth quarter 2022
Fourth quarter 2022 iil Strong growth with Key Financial Strategic $815 million in revenue Highlights Highlights 20% organic revenue growth! Delivered record quarterly Received FDA clearance for G7, (17% US; 27% OUS?) non-GAAP EPS enabling U.S. launch early in 2023 Generated nearly 800 basis points
Slide 4: Fourth quarter performance
Fourth quarter performance Total Revenue & Organic Growth Rate! Non-GAAP Gross Profit and % Margin* ($mm) ($mm) 770 $815 494, $544 $800 | $698 $629 $696 $ gsoo | $473 $398 $450 $ $600 $400 $300 $400 $200 or + 20% +23% +16% +20% +20% Selo 67.7% 63.3% 64.6% 64.2% 66.7% $0 $0 Q4'21 Q122 Q2'22 Q3'22 Q4'
Slide 5: 2023 Guidance as of February 9, 2023
2023 Guidance as of February 9, 2023 2023 Annual Revenue and Profitability Guidance Non-GAAP. Non-GAAP Adjusted . . Revenue Gross Profit Margin Operating Margin EBITDA Margin* Key Considerations + Global rollout of G7 + Expansion of Dexcom ONE USD into new geographies 3.35-3.49 62-63% ~16.5% ~26% +
Slide 6: Appendix: Revenue Data and GAAP Reconciliations
bexcom Appendix Revenue Data and GAAP Reconciliations
Slide 7: DexCom, Inc.
DexCom, Inc. ‘Three Months Ended December 31, 2022, 2021 (in mifions) (As Adjusted)* GAAP gross profit s 543 § 4728 Amortization of intangible assets 2.4 Non-GAAP gross profit 5437 428. GAAP operating income 8 125.4 § os ‘Amortization of intangible assets “ 42 14 Business transition and related cost
Slide 8: Itemized Reconciliation between GAAP and Non-GAAP Financial Measures
DexCom, Inc. Itemized Reconciliation between GAAP and Non-GAAP Financial Measures Bolow is @ summary of the changes in our “Itemized Reconciliation Betwoon GAAP and Non-GAAP Financial Measures’ wo originaly reported for the thre months ended December 31, 2021 under the ASC 470-20 legacy guidance com
Slide 9: Revenue Metrics By Component
Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 FY'20 FY'21 FY'22 Revenue Metrics By Component Sensor & Other Revenue (millions) (1) (2) $ 325.0 $ 364.5 $ 406.3 $ 465.6 $ 424.3 $ 494.5 $ 547.9 $ 598.6 $ 543.2 $ 597.7 $ 666.6 $ 714.8 $ 1,561.4 $ 2,065.3 $ 2,522.3 Year over yea
Slide 10: Revenue Metrics By Geography
Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 FY'20 FY'21 FY'22 Revenue Metrics By Geography US Revenue (millions) $ 292.3 $ 367.1 $ 398.6 $ 451.5 $ 381.2 $ 461.5 $ 489.6 $ 517.1 $ 451.2 $ 511.0 $ 573.4 $ 606.4 $ 1,509.5 $ 1,849.4 $ 2,142.0 Year over year growth 39% 38% 29%
Slide 11: Organic Revenue
Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 FY'20 FY'21 FY'22 1 Organic Revenue OUS Revenue - Reported $ 112.8 $ 84.7 $ 102.3 $ 117.4 $ 123.8 $ 133.6 $ 160.6 $ 181.1 $ 177.6 $ 185.2 $ 196.2 $ 208.8 $ 417.2 $ 599.1 $ 767.8 Impact of Acquired Revenue and Foreign Exchange 1.
Slide 12: Definitions
DexCom, Inc. Definitions: Amortization of intangible assets — We are required by GAAP to record the fair values of the intangible assets of the entity on our balance sheet and amortize them over their useful lives. We exclude these non-cash amortization charges related to acquired intangible assets